Purchase Order 75F40124P00471
Award Date
9/25/24
Potential Completion Date
9/24/29
Potential Value
$356K
Federal Agency
Food and Drug Administration
Awardee
Analygence, Inc.
Ultimate Awardee
Not listed
NAICS Category
541519 - Other Computer Related Services
PSC Category
DA01 - It And Telecom - Business Application/Application Development Support Services (Labor)
Federal Contract Vehicle
Set-Aside Type
8(a) Sole Source
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fulton, MD 20759, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Food and Drug Administration (FDA) has awarded a single-award, labor-hour (LH) contract to Aneon Brillient, LLC, an SBA certified 8(a) joint venture small disadvantaged business, to provide Freedom of Information Act (FOIA) support services for the FDA's Center for Biologics Evaluation and Research (CBER). This $1,479,584.76 ceiling value contract is a direct 8(a) sole source award with a period of performance through August 27, 2025. Aneon Brillient, a minority-owned limited...
This is a $164,940.82 sole source 8(a) contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned small disadvantaged business. The contract is for database administration support for the FDA's Center for Drug Evaluation and Research (CDER). The contract is a labor-hour type with a completion date of September 25, 2026. Aneon Brillient, an SBA certified 8(a) joint venture, has extensive experience providing professional services to the FDA, including...
This federal contract award was issued by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) to support the Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative. The $8,234,421.12 delivery order contract will develop new and innovative methods for automated reporting for CBER-regulated biologics. The contract is a Time and Materials (T&M) type and does not have a set-aside designation. IBM will be...
The U.S. Food and Drug Administration (FDA) has awarded a $4,477,388.51 time and materials contract to Advanced Network Consulting, Inc., an 8(a) certified minority-owned small disadvantaged business, to provide logistics and supply management support services for the Center for Devices and Radiological Health (CDRH) Office of Strategic Partnership and Technology Innovation (OSPTI) in response to the COVID-19 pandemic. The contract, which is set to expire on May 30, 2024, was awarded on a sole...
The U.S. Food and Drug Administration (FDA) awarded an 8(a) sole source contract to Aneon Brillient, LLC, a minority-owned small disadvantaged business, to provide administrative staffing services for the Center for Drug Evaluation and Research (CDER). The 12-month base contract with a 1-year option period has a ceiling value of $186,092.22 and is a labor-hour type contract. This award demonstrates Aneon Brillient's ongoing support to the FDA, as evidenced by their prior 8(a) sole source...
This is a Firm Fixed Price Blanket Purchase Agreement (BPA) call contract awarded by the Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The $28,209,345.33 contract supports the FDA's "ADVANCING REGULATORY SCIENCE FOR CLINICAL EVIDENCE GENERATION, ASSESSMENT, AND ANALYTICS" initiative, providing a range of data analytics, AI/ML, healthcare IT, and management consulting services...
The Department of Health and Human Services Food and Drug Administration awarded a $2.68 million delivery order against the BEST Initative - Data Sources For Surveillance of Biologics master IDIQ to Iqvia Government Solutions Inc. The one-year order, with a period of performance from September 2020 through September 2021, will provide products and services in support of the BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: DATA SOURCES FOR SURVEILLANCE OF BIOLOGICS effort. Under a time...
This federal contract was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Acumen LLC, doing business as Medric, to develop and enhance the FDA's Center for Biologics Evaluation and Research (CBER) capabilities with respect to electronic health data sources, infrastructure, methods, and tools. The purpose is to conduct surveillance and epidemiologic studies to assure the safety and effectiveness of biologic products including vaccines, blood...
The Food and Drug Administration (FDA) awarded a $499,968.65 firm fixed price delivery order contract to Sagacity Ventures LLC, an SBA-certified 8(a) joint venture small business. The contract is for the operation and maintenance of an Access database in support of the FDA's Bioresearch Monitoring (BIMO) Program and COVID-19 initiatives. This delivery order was issued under the 8(a) STARS III Government-Wide Acquisition Contract (GWAC), a $50 billion multiple-award contract vehicle set aside for...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $13.2 million delivery order contract to International Business Machines Corporation (IBM) under the Biologics Effectiveness and Safety (BEST) Initiative - Data Tools and Infrastructure for Surveillance of Biologics indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The contract calls for IBM to provide data, tools, and infrastructure to support HHS FDA's BEST Initiative for surveillance of...